Volume 70, Issue 2, Pages (August 2016)

Slides:



Advertisements
Similar presentations
Volume 68, Issue 6, Pages (December 2015)
Advertisements

Volume 194, Issue 2, Pages (August 2015)
The PSA Era is not Over for Prostate Cancer
Volume 50, Issue 1, Pages (July 2006)
Volume 69, Issue 3, Pages (March 2016)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 2, Pages (August 2010)
Volume 44, Issue 6, Pages (December 2003)
Volume 58, Issue 4, Pages (October 2010)
Volume 66, Issue 6, Pages (December 2014)
Volume 60, Issue 2, Pages (August 2011)
Prostate Cancer: Highlights from 2006
Volume 49, Issue 2, Pages (February 2006)
Volume 61, Issue 5, Pages (May 2012)
Volume 74, Issue 2, Pages (August 2018)
Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey  Varant Kupelian,
Volume 46, Issue 3, Pages (September 2004)
Volume 67, Issue 3, Pages (March 2015)
Volume 53, Issue 5, Pages (May 2008)
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Volume 69, Issue 1, Pages (January 2016)
Volume 51, Issue 4, Pages (April 2007)
Louis Spencer Krane, Mahendra Bhandari, James O. Peabody, Mani Menon 
Volume 73, Issue 5, Pages (May 2018)
Prostate Cancer Epidemic in Sight?
Volume 63, Issue 1, Pages (January 2013)
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 53, Issue 4, Pages (April 2008)
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 68, Issue 3, Pages (September 2015)
Volume 67, Issue 3, Pages (March 2015)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 67, Issue 6, Pages (June 2015)
Volume 71, Issue 5, Pages (May 2017)
Volume 71, Issue 6, Pages (June 2017)
Counselling the Prostate Cancer Patient
Volume 54, Issue 2, Pages (August 2008)
Volume 53, Issue 4, Pages (April 2008)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 6, Pages (June 2008)
Volume 66, Issue 6, Pages (December 2014)
Volume 66, Issue 6, Pages (December 2014)
Volume 61, Issue 2, Pages (February 2012)
Volume 66, Issue 2, Pages (August 2014)
Volume 58, Issue 1, Pages 1-7 (July 2010)
Volume 62, Issue 4, Pages (October 2012)
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
Volume 70, Issue 2, Pages (August 2016)
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
Volume 50, Issue 2, Pages (August 2006)
Volume 71, Issue 5, Pages (May 2017)
Testicular Cancer Variations in Time and Space in Europe
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
European Urology is “Your” Journal
Volume 53, Issue 5, Pages (May 2008)
Volume 54, Issue 2, Pages (August 2008)
Volume 54, Issue 1, Pages (July 2008)
Management of Prostate Cancer: Global Strategies
Volume 53, Issue 2, Pages (February 2008)
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Volume 54, Issue 3, Pages (September 2008)
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 70, Issue 2, Pages 248-253 (August 2016) Size-adjusted Quantitative Gleason Score as a Predictor of Biochemical Recurrence after Radical Prostatectomy  Fang-Ming Deng, Nicholas M. Donin, Ruth Pe Benito, Jonathan Melamed, Julien Le Nobin, Ming Zhou, Sisi Ma, Jinhua Wang, Herbert Lepor  European Urology  Volume 70, Issue 2, Pages 248-253 (August 2016) DOI: 10.1016/j.eururo.2015.10.026 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 Biochemical disease free survival of patients with Gleason 7 cancers stratified by (A) percentage of Gleason 4 disease (<11%, 11–50%, >50%), (B) size index Gleason score (<0.1, 0.1–0.5, >0.5), and (C) size-weighted Gleason score (<0.1, 0.1–0.5, >0.5). GS=Gleason score; siGS=size index Gleason score; swGS=size-weighted Gleason score. European Urology 2016 70, 248-253DOI: (10.1016/j.eururo.2015.10.026) Copyright © 2015 European Association of Urology Terms and Conditions